From June 5438 to 1996 10, immunoglobulin solution for intravenous injection (5%50m) was rated as 1996 national new product, and human prothrombin complex was rated as 1996 national new product.
From June 5438 to 1996 10, human fibrinogen was rated as 1996 national new product.
1September, 1997, the company ranked first in the "1Top Ten Biological Products Sales in Shanghai in 1996" selected by Shanghai Statistics Bureau.
19991On October 24th, Vice Chairman Huang Kai was awarded the honorary citizen certificate of Shanghai.
On June 30th, 2000, the company's "albumin purification method" was patented by China National Intellectual Property Administration.
On July 6th, 0 1 year, the company's "liquid preparation of immune serum globulin for intravenous injection and its preparation method" won the invention patent of China National Intellectual Property Administration.
0165438+On February 27th, the company's "Basic and Clinical Research on Hemophilia" won the second prize of Shanghai Science and Technology Progress Award.
0 1 10 On February 28th, the company's "Basic and Clinical Research on Hemophilia" won the third prize of "China Medical Science and Technology Award" issued by Chinese Medical Association.
065438+2002128 October, freeze-dried fibrin glue for external use (Tiger Bone Laishi) was awarded the Shanghai High-tech Achievements Transformation Project.
065438+28 In 2002 10, freeze-dried human thrombin (Suprax) won the Shanghai High-tech Achievement Transformation Project.
In August 2002, the company was selected as one of the "Top 500 Industrial Enterprises in Shanghai in 20001Year".
On June 0/0/9, 2004, the company obtained the GMP Certificate issued by the State Administration of Pharmaceutical Products.
On March 30th, 2005, Vice President Huang Kai was elected as the director of the fifth Council of Shanghai Association of Foreign-invested Enterprises.
In 2006, Huajie Credit Rating Co., Ltd., authorized by Shanghai Branch of China People's Bank, was rated as "AAA Enterprise Credit Rating in Shanghai" by the Credit Rating Expert Committee.
On June 0 1 day, 2007, the company was selected as an advanced technology enterprise with foreign investment in Shanghai by Shanghai Foreign Investment Working Committee and Shanghai Foreign Economic and Trade Commission.
On July 6, 2007, the company passed the ISO900 1:2000 audit again.
On September 10, 2007, the company was recognized as a "high-tech enterprise" by Shanghai Science and Technology Commission.